Santa Clara University

Bill

Internship and Residency, Pediatrics, University of Kentucky, Albert B. Chandler Medical Center, Lexington, Kentucky, 1977-1980

Chief Resident, Pediatrics, University of Kentucky, Albert B. Chandler Medical Center, Lexington, Kentucky, 1980-1981

Clinical Fellow, Pediatric Endocrinology and Diabetes, Department of Pediatrics, University of Florida, College of Medicine, Gainesville, Florida, 1981-1982

Research Fellow, Pediatric Endocrinology and Diabetes, Departments of Pathology and Laboratory Medicine and Pediatrics, University of Florida, College of Medicine, Gainesville, Florida, July 1982 - April 1984

Research Assistant Professor of Pathology and Laboratory Medicine and Pediatrics, University of Florida, Gainesville, Florida, May 1984-June 1985

Assistant Professor of Pathology and Laboratory Medicine and Pediatrics, University of Florida, Gainesville, Florida, July 1985 - August 9, 1990

Associate Professor of Pathology and Laboratory Medicine, Pediatrics and Immunology and Medical Microbiology, University of Florida, Gainesville, Florida, August 10, 1990 - August 1996

Residency Program Director, Department of Pathology and Laboratory Medicine, May 1992 - 1996; May 1998- present

Technical Supervisor for Clinical Chemistry, Gainesville Veterans Administration Medical Center, 1995-present

Technical Supervisor for Ancillary Testing, Gainesville Veterans Administration Medical Center, 1995-present

Professor of Pathology, Immunology and Laboratory Medicie, Pediatrics, Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, August 1996 - present

Director of Endocrine Autoantibody Laboratory of Diagnostic Referral Laboratory, June 9, 1997 - present

BOARDS: American Board of Pediatrics, February 1982

Pediatric Endocrinology, American Board of Pediatrics, November 1983

American Board of Clinical Chemistry (ABCC), July 1990

American Board of Pathology, Chemical Pathology, May 31, 1993

PUBLICATIONS: (Does not include chapters, books or abstracts)

1. Winter, W.E., Rosenbloom, A.L., Maclaren, N.K., Mickle, J.P.: Solitary central maxillary incisor associated with precocious puberty and hypothalamic hamartoma. J Pediatr 1982; 101:965-967.

2. Monif, G.R., Hardt, N.S., Donnelly, W.H., Winter, W.: Neural crest cell migration to placenta. Amer J Clin Path 1983; 79:141.

3. Winter, W.E., Silverstein, J.H., Maclaren, N.K., Riley, W.J., Chiaro, J.J.: Autosomal dominant hypoparathyroidism with variable, age-dependent severity. J Pediatr 1983; 103:387-390.

4. Winter, W.E., Silverstein, J.H., Barrett, J.D., Kiel, E.: Familial DiGeorge Syndrome with tetralogy of Fallot and prolonged survival. Eur J Pediatr 1984; 141:171-172.

5. Winter, W.E., Maclaren, N.K., Riley, W.J., Unger, R.H., Ozand, P., Neufeld, M.: Pancreatic alpha cell autoantibodies and glucagon response to arginine. Diabetes 1984; 33:435-437.

6. Hensen, V., Maclaren, N.K., Winter, W., Riley, W., Rotter, J., Wakeland, E.K.: The molecular genetics of insulin dependent diabetes mellitus. Mol Biol & Med 1986; 3:129-136.

7. Winter, W.E., Maclaren, N.K., Riley, W.J., Andres, J., Toskes, R.P., Rosenbloom, A.L. Congenital pancreatic hypoplasia: a novel diabetes syndrome of exocrine and endocrine pancreatic insufficiency. Pediatrics 1986; 109:465-469.

8. Atkinson, M.A., Maclaren, N.K., Riley, W.J., Winter, W.E., Fisk, D.D., Spillar, R.P.: Are insulin autoantibodies markers for insulin dependent diabetes? Diabetes 1986; 35:894-898.

9. Skordis, N., Winter, W.E., Maclaren, N.K.: Acute-Onset Diabetes. Reversing diabetic ketoacidosis. Drug Therapy 1986; 16:26-42.

10. Winter, W.E., Beppu, H., Maclaren, N.K., Cooper, D.L., Bell, G.I., Wakeland, E.K.: Restriction fragment length polymorphisms in the 5' flanking region of the insulin I gene in the BB rat and other rat strains and absence of association with insulin dependent diabetes mellitus. Diabetes 1987; 36:193-198.

11. Winter, W.E., Maclaren, N.K., Riley, W.J., Clarke, D.W., Kappy, M.S., Spillar, R.P.: Maturity-onset diabetes of youth in Black Americans. New Engl J Med 1987; 316:285-291.

12. Maclaren, N.K., Silverstein, J.H., Spillar, R.P., Skordis, N., Winter, W.E., Riley, W.J.: Immunosuppressive therapy in insulin dependent diabetes. Acta Pediatrica Japonica 1987; 29(3):349-354.

13. Winter, W.E., Riley, W.J., Maclaren, N.K.: Maturity-onset diabetes in young Black Americans (letter). New Engl J Med 1987; 317:382.

14. Maclaren, N., Riley, W., Winter, W., Silverstein, J.H.: Is insulin dependent diabetes mellitus a preventable disease? Clin Invest Med 1987; 10:444-449.

15. Beppu, H., Winter, W.E., Atkinson, M.A., Maclaren, N.K., Fujita, K., Takahashi, H.: Bovine albumin antibodies in NOD mice. Diabetes Research 1987; 6:67-69.

16. Riley, W.J., Winter, W.E., Maclaren, N.K.: Can insulin dependent diabetes mellitus (IDD) be identified prior to the onset of clinical symptoms. J Pediatrics 1988; 112:314-316.

17. Winter, W.E., Riley, W.J., Maclaren, N.K.: Familial diabetes mellitus (letter). Diabetologia 1988; 31:127-128.

18. Winter, W.E., Robbins, V., Elder, M., Barrett, D., Martin N., Maclaren, N.K.: Thymosin an the spontaneously diabetic BB rat. Autoimmunity 1988; 1:115-123.

19. Atkinson, M.A., Winter, W.E., Skordis, N., Beppu, H., Riley, W.J., Maclaren, N.K.: Dietary protein restriction reduces the frequency and delays the onset of insulin dependent diabetes in BB rats. Autoimmunity 1988; 2:11-20.

20. Schatz, D.A., Kowa, H., Winter, W.E., Riley, W.J.: The natural history of incidental hyperglycemia and/or glycosuria of childhood. J Pediatrics 1989; 115:676-80.

21. Shimpo, K., Obata, M., Yamada, K., Beppu, H., Luchetta, R., Winter, W.E.: Relationship of insulitis and A and T-cell receptor genes in [(NOD x NZW) F1 x NOD] first backcross mice. Medicine and Biology 1990; 120(4):185-190.

22. Rosenbloom, A.L. and Florida Academic Pediatric Endocrinologists (Winter, W.E.): Height Screening in the Community, the Commercialization of Growth and the Role of the Pediatrician. Clinical Pediatrics 1990; 29(5):288-292.

23. Winter, W.E., Shimpo, K.; Obata, M., Yamada, K., Luchetta, R.: Immunogenetic analysis of beta cell autoimmunity in the NOD mouse: The relationship of insulitis to the A nod gene and the T cell receptor nod gene. Diabetes 1990; 39:975-982.

24. Winter, W.E., Bertholf, R.L., Riley, W.J., Maclaren, N.K., Obata, M., Allen, L.: Hypercholesterolemia: a common problem in Florida school-age children and adolescents. Annals of New York Academy of Sciences 1991; 623:472-475.

25. Jarpe, A.J., Winter, W.E., Peck, A.B.: The changing profile of monoclonal cell populations infiltrating the islets of Langerhans during the progressive insulitis phase in prediabetic NOD mice. Allergy & Immunology (Life Sci Adv) 1991; 9:283-292.

26. Winter, W.E.: Atypical diabetes in Blacks. Clinical Diabetes 1991; 9(4):49-56.

27. Winter, W.E., Obata, M., Muir, A., Maclaren, N.K.: Heritable origins of type I, insulin dependent diabetes mellitus. Growth, Genetics & Hormones 1991; 7(2):1-6.

28. Jarpe, A.J., Hickman, M.R., Anderson, J.T., Winter, W.E., Peck, A.B.: Flow cytoetric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type 1 diabetes. Regional Immunology 1991; 3(6):305-317.

29. Winter, W.E., Atkinson, M.A.: Getting to the root of type I diabetes. Diabetes Forecast 1992; 45(5):34-38.

30. Winter, W.E., Yamada, K., Shimpo, K., Wakeland, E.K.: T cell receptor beta in the NOD mouse: Analysis of the variable region diversity and joining segments. Autoimmunity 1992; 12:9-12.

31. Winter, W.E., Funahashi, M., Koons, J.: Encainide-induced diabetes: analysis of islet cell function. Research Communications in Clinical Pathology and Pharmacology 1992; 76(3):259-268.

32. Obata, M., Shimpo, K., Funahashi, M., Fujita, K., Luchetta, R., Winter, W.E.: Linkage analysis between , , T cell receptor alleles and insulitis in [NOD/Uf x NZW) F1 x NOD/Uf] first backcross mice. Medicine and Biology 1992; 125(6):245-249.

33. Obata, M., Shimpo, K., Funahashi, M., Fujita, K., Cheng, I., Luchetta, R., Winter, W.E.: Relationship of genetic markers on chromosome 9 (Thy-1 and P-450) to insulitis in [NOD/Uf x NZW) F1 x NOD/Uf)] first backcross mice. Medicine and Biology 1992; 125(6):251-254.

34. Winter, W.E., Weber, J., Sleater, J., Bertholf, R.L.: The relationship of T-Uptake and T4 in hypo- and hyperthyroid patients. Clinical Chemistry 1993; 39:554.

35. Anderson, J.T., Cornelius, J.G., Jarpe, A.J., Winter, W.E., Peck, A.B.: Insulin-dependent diabetes in the NOD mouse model II. -cell destruction in autoimmune diabetes is a TH2 and not a TH1-mediated event. Autoimmunity 1993; 15:113-122.

36. Shieh, D.C., Cornelius, J.G., Winter, W.E., Peck, A.B.: Insulin-dependent diabetes in the NOD mouse model I. Detection and characterization of autoantibody bound to the surface of pancreatic beta cells prior to development of the insulitis lesion in prediabetic NOD mouse. Autoimmunity 1993; 15:123-135.

37. Winter, W.E., Hardt, N.S.: Pediatric apprach to prevention of coronary heart disease. Florida Medical Journal 1993; 80:679-683.

38. Winter, W.E.; Chihara, T.; Schatz, D.A.: The genetics of autoimmune diabetes. American Journal of Diseases of Children 1993; 147:1282-1290.

39. Winter, W.E.: Molecular Mechanisms for Sensory Signals, by E.M. Kosower. In: E. Bauliu and P. Kelly (eds) (review), Human Biology 1993; 65:1046-1047.

40. Winter, W.E., Varga-House, D.A., Chihara, T.: TH1 vs. TH2 cells in autoimmune diabetes mellitus. Diabetes Prevention and Therapy 1994; 8:1-6.

41. Schatz, D., Krischer, J., Horne, G., Riley, W., Spillar, R., Silverstein, J., Winter, W., Muir, A., Derovanesian, D., Shah, S., Malone, J., Maclaren, N.: Islet cell antibodies predic insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. Journal of Clinical Investiation 1994; 93:2403-2407.

42. Winter, W.E.: Gland alert. Diabetes Forecast 1995; 48:34-39.

43. Winter, W.E., House, D.V.: Failure to thrive, cataracts, jaundice, and hypoglycemia in a 6 week old infant. AACC Diagnostic Endocrinology and Metabolism In-Service Training and Continuing Education 1995; 13(5):135-136.

44. Winter, W.E.: Laboratory approaches to the evaluation of hypoglycemia. AACC Endocrine/Toxicology In-Service Training and Continuing Education 1995; 13(5):139-150.

45. Winter, W.E., Nakamura, M.: Euthyroid hyperthyroxinemia. AACC Diagnostic Endocrinology and Metabolism In-Service Training and Continuing Education 1996; 14(1):3-6.

46. Winter, W.E.: The immunoendocrinopathies. Part 1: Overview and insulin-dependent diabetes mellitus. AACC Diagnostic Endocrinology and Metabolism In-Service Training and Continuing Education 1996; 14(1):13-21.

47. Winter, W.E.: The immunoendocrinopathies. Part 2: Autoimmune thyroid disease, autoimmune Addison disease, and related disorders. AACC Diagnostic Endocrinology and Metabolism In-Service Training and Continuing Education 1996; 14(2):45-52.

48. Winter, W..: Accident, overdose, suicide, and homicide: What the toxicologist needs to know about hypoglycemia. AACC Therapeutic Drug Monitoring and Toxicology In-Service Training and Continuing Education 1996; 17(3):59-72.

49. Winter, W.E., Nakamura, M.: The case of the boy with abdominal pain: the family history tell all. AACC Diagnostic Endocrinology and Metabolism In-Service Training and Continuing Education 1996; 14(4):93-96.

50. Schatz, D., Winter, W.: Recent advances in the immunopathogenesis of insulin-dependent diabetes mellitus. Current Opinion in Pediatrics August 1995; 7(4): 459-65.

51. Winter, W.E., Nakamura, M.: Endocrine disorders and human immunodeficieny virus infection. AACC Diagnostic Endocrinology and Metabolism In-Service Training and Continuing Education 1996; 14(6):157-167.

52. House, D.V., Winter, W.E.: Scars or Cheloids: Things are not always what they seem. AACC Diagnostic Endocrinology and Metabolism In-Service Training and Continuing Education 1996; 14(7):183-188.

53. House, D.V., Winter, W.E.: Olympic victory at any cost: The metabolic effects of performance-enhancing drugs. AACC Diagnostic Endocrinology and Metabolism In-Service Training and Continuing Education 1996; 14(8):221-228.

54. House, D.V., Winter, W.E.: Progressive elevations in thyroid-stimulating hormone: The clinical Challenge. AACC Diagnostic Endocrinology and Metabolism 1996; 14(11):303-306.

55. Winter, W.E.: Cecil Textbook of Medicine, 20th Edition: Bennett, J.C. and Plum, F. (Eds). W.B. Saunders Company, Philadelphia, PA; (Review), Clinical Chemistry 1996; 43(8):1470.

56. House, D.V., Winter, W.E.: The role of radionucleotide studies in the evaluation of thyroid function. Part 1: The radioactive iodine uptake test. AACC Diagnostic Endocrinology and Metabolism 1996; 14(12):335-339.

57. Winter, W.E.: Type I, insulin-dependent diabetes mellitus: a model for autoimmune polygenic disorders. Advances in Dental Research 1996; 10(1):81-87.

58. House, D.V., Nakamura, ., Winter, W.E.: Hypercalcemia in a child with a rare immunodeficiency syndrome. AACC Diagnostic Endocrinology and Metabolism 1997 15(4):97-101.

59. Hardt, N.S., Nakamura, M., Winter, W.E.: Infectious disease testing in the clinical chemistry laboratory: The biology of the human immunodeficiency virus-1. AACC Diagnostic Endocrinology and Metabolism 1997; 15(4):91-95.

60. Hardt, N.S., Nakamura, M., Winter, W.E.: Infectious disease testing in the clinical chemistry laboratory: The laboratory diagnosis of human immunodeficiency virus-1. AACC Diagnostic Endocrinology and Metabolism 1997; 15(5):127-132.

61. Winter, W.E., House, D.V., Schatz, D.: Pharmacologic approaches to the prevention of autoimmune diabetes. Drugs 1997; 53(6):943-956.

62. Winter, W.E., Nakamura, M.: The case of a man with cardiovascular disease, hypertension, and headaches. AACC Diagnostic Endocrinology and Metabolism 1997; 15(8): 231-235.

63. Winter, W. E., House, D.V.: Lipids in Kids. AACC Diagnostic Endocrinology and Metabolism 1997; 15(8): 239-252.

64. Winter, W.E., Nakamura, M.: ADA/WHO Release New Guidelines for the Diagnosis of Diabetes Mellitus. AACC Diagnostic Endocrinology and Metabolism 1997; 15(10):299-301.

65. Winter, W.E., Schatz, D.: Neonatal prevention of IDDM? (letter). Diabetes Prevention and Therapy September 1997; 2(3):17-8.

66. Winter, W.E., Nakamura, M.: Where's the hemoglobin A1c? AACC Diagnostic Endocrinology and Metabolism 1997; 15(11):329-31.

67. House, D.V., Winter, W.E.: Autoimmune diabetes: the role of autoantibody markers in the prediction and prevention of insulin-dependent diabetes mellitus. Clinics in Laboratory Medicine. 1997; 17(3):499-545.

68. Winter, W. E., House, D.V.: Syndrome X: The insulin resistance syndrome. AACC Diagnostic Endocrinology and Metabolism 1998; 16(1): 15-22.

69. Winter, W.E., House, D.V.: Hypercholesterolemia in a 12-y-old girl. AACC Diagnostic Endocrinology and Metabolism 1998; 16(2):39-42.

70. Rosenbloom A.L., Huse D.V., Winter, W.E.: Non-insulin dependent diabetes mellitus (NIDDM) in minority youth: research priorities and needs. Clinical Peds 1998; 37 (2):143-52.

71. Winter,W.E., Nakamura,M.: The Relationship of the c-RET Proto-Oncogene to familial forms of medullary thyroid carcinoma. AACC Immunonotes Winter 1998; 13-19.

72. Winter,W.E., House, D.V,: HIV testing in infants and children., AACC Diagnostic Endocrinology and Metabolism. 1998; 16(3): 63-6

73. Winter,W.E.,: "Unexpected Peaks," or "Why is Mount Everest present on my HPLC hemoglobin A1c tracing?" AACC Diagnostic Endocrinology and Metabolism. 1998; 16(3):67-72

74. Winter, W.E., House, D, V.: Cushing syndrome with normal pituitary MRI: What do you do next? AACC Diagnostic Endocrine and Metabolism 1998; 16 (6): 159-163.

75. Winter, W.E., House, D. V.: The Genetics of type 2 diabetes mellitus: the clinical chemist as molecular diabetologist in the 21st century. AACC Diagnostic Endocrinology and Metabolism 1998;16 (6): 159-90.

76. Winter,W.E.: The case of the cloudy serum. AACC Diagnostic Endocrinology and Metabolism 1998;16 (7): 197-99.

77. Winter,W.E.: New developments in the genetics of the multiple endocrine neoplasia (MEN) syndromes. AACC Diagnostic Endocrinology and Metabolism 1998;16(9):225-58.

78. Winter,W.E.: Evaluation of endocrine hypertension. AACC Diagnostic Endocrinology and Metabolism 1998;16(10) 297-315.

79. Winter,W.E.: Persistent, severe neonatal hypoglycemia in the absence of maternal diabetes mellitus: familial hyperinsulinism and inborn errors in -cell function.AACC Diagnostic Endocrinology and Metabolism 1998;16(10) 287-88.

80. Winter, W.E.: Type 2 diabetes mellitus: the challenge of a metabolic epidemic. Journal of Clinical Ligand Assay 1998: 21 (3) 293-308.

81. Hardt, N.S.,Winter, W.E.,: Progressive hypertriglyceridemia in a child with human immunodeficiency virus-type 1infection. Diag Endo, Immunol, & Metab 1999: 17(2):
39-42.

82. Rosenbloom, A.L., Joe, J.R.,Youn, R.S., Winter, W.E.: Emerging Epidemic of Type 2 Diabetes in Youth. Diabetes Care 1999: 22(2): 345-354.

83. Winter,W.E., The Use of Islet Autoantibody Markers in the Prediction of Autoimmune Type 1 Diabetes. Clinical Immunology Newsletter 1999: 19(3): 25-39.

84. Winter, W.E., House, D.V., Schatz, D.: Measuring and managing lipid levels. Contemporary Pediatrics, 1999: 16(5): 96-105.

85. Winter, W.E., Additional Assay for Type 1 Diabetes. (letter) Advance/Laborarory 1999 8: 14-15.

86. Winter,W.E., Hardt, N., Glucose transporters in the news: The Fanconi-Bickel syndrome. Diag. Endo, Immunol, & Metab 1999: 17(7): 195-98.

87. Winter, W.E., Hardt, N., Acute-onset diabetes mellitus: metabolic perturbations in a 37-year-old African-American woman. Diag. Endo, Immunol, Metab 1999: 17(8): 225-29.

88. Winter, W.E., Hardt, N.S., Clinical laboratory evaluation of short stature in children. Diag. Endo, Immunol, Metab 1999:17(9): 265-76.

89. Penson, M.G., Winter, W.E., Fricker, F.J., Harker, K., Kahler,D.A., Kubilis, P.S., Schowengerdt, K.O.: Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients. J Heart Lung Transplant. 1999 Jul; 18(7): 707-13

90. Winter, W.E.,The case of the untimed thyropin-releasing hormone test.
Diag. Endo, Immunol, Metab 1999:17(11): 319-321.

91. Winter,W.E., Hardt, N.S.,The endocrinology of growth failure. Medical Laboratory Observer.1999:31(12):30-37.

92. Winter, W.E., Nakamura, M., House D.V., Monogenic Diabetes Mellitus in Youth: The MODY syndromes. Endocrinology and Metabolism Clinics of North America. 1999:28(4): 765-785.

93. Winter, W.E., Oral Agent Pharmacotherapy for Type 2 Diabetes Mellitus: The New Armamentarium. Therapeutic Drug Monitoring and Toxicology. 2000; 21(1): 9-23.

94. Winter, W.E., Guidelines for the laboratory assessment of diabetes mellitus. AACC Diagnostic Endocrinology, and Metabolism. 2000:18(2): 49-68

95. Winter, W.E.: Real time monitoring in the care of idividuals with diabetes mellitus.
Clinical Laboratory News 2000: 26(6) 12-15

96. Winter, W.E., Hardt,N.S.: Controversies in the diagnosis of diabetes mellitus. Diag Endo, Immunol, & Metab 2000: 19(3):75-78

97. Schatz, D.A., Winter, W.E.: Future Type 1 Diabetes Prevention Trials: From Bench to Bedside. Medscape Diabetes & Endocrinology June 12, 2000. Available at: http://endocrine.medscape.com/Medscape/CNO/2000/ADA/public/Conference.cfm?conference_id=54

98. Schatz DA, Winter WE. Diagnosis and treatment of possible maturity onset diabetes of youth. Available at:
http://diabetes.medscape.com/Medscape/endocrinology/AskExperts/2000/11/ENDO-ae12.html

99. Winter, W.E.,: Evaluating calcium disorders. Advance/Laboratory 2000; 9(7):30-45.

100. Winter, W. E., Silverstein, J.H.: Molecular and genetic bases for maturity onset diabetes of youth. Current Opinion in Pediatrics 2000; 12(4): 388-93.

101. Winter, W.E., The endocrinology of disorders of sexual development: Part I. AACC Diagnostic Endocrinology, and Metabolism. 2000: 18(7): 207-227.

102. Winter, W.E., Hardt N.S., Fuhrman S.: Immunoglobulin E: Importance in parasitic infections and hypersensitivity responses. Archives of Pathology and Laboratory Medicine 2000; 124(9):1382-1385

103. Winter, W.E., The endocrinology of disorders of sexual development: Part II. AACC Diagnostic Endocrinology, and Metabolism. 2000: 18(8): 247-270.

104. Winter, W.E., The case of two too many endocrinopathies. AACC Diagnostic Endocrinology, and Metabolism. Sept. 2000 18(9): 287-290.

105. Winter, W.E., A commentary on transplantation. AACC Diagnostic Endocrinology, and Metabolism. Sept. 2000 18(9): 291-2292.

106. Winter, W.E., NACB Recommendations for the Use of Cardiac Markers. AACC Diagnostic Endocrinology, and Metabolism. Dec. 2000 18 (12) : 371-372

107. Winter, W.E. Molecular and biochemical analysis of the MODY syndromes. Pediatric Diabetes 2000; 1:88-117.

108. Geffken G., Winter, W. E., Hardware and software in diabetes mellitus:Performance characteristics of hand-held glucose testing devices and the application of glycemic testing to patients' daily diabetes management. Clinical Chemistry 2001, 47(1):11-12.

109. Winter, W. E.: Growth hormone deficiency (adult), Growth hormone deficiency (pediatric), UPCMD, at: http://upcmd.com/dot/authors_dot.html ,2001

110. Elin, R.J., Winter, W.E.: Methylmalonic Acid: A test whose time has come. Archives of Pathology & Laboratory Medicine June 2001, 125 (6): 824-27.

111. Winter, W.E., Signorino, M.R.: Review; Molecular Thyroidology. Annuals of Clinical Laboratory Science. 2001, 21 (3): 221-44.

112. Winter, W.E., Schatz, D.A. Pediatric Lipid Disorders in Clinical Practice. emedicine, 2001, Available at: http://www.emedicine.com/ped/topic2787.htm

113. Winter W.E., Schatz D.A.: Characterisitcs of atypical diabetes mellitus, at: http://diabetes.medscape.com/45553.rhtml?srcmp=endo-113001

114. Diabetes Prevention Trial *Type 1 Diabetes Study Group. Effects of insulin in relatives of patients With type 1 diabetes mellitus. N Engl J Med 2002; 346:1685-91

115. Winter WE: The use of insulin in critically ill patients. Current Diabetes Reports 2002; 2(2):109-110.

116. Schatz, DA, Winter WE:Outcomes of Type 1 Diabetes Prevention Trials. Available at: Medscape from WebMD, http://www.medscape.com/viewarticle/436017; 2002

117. Schatz DA, Winter WE: Autoimmune polyglandular syndrome II: clinical syndrome and treatment. Endocrinology and Metabolism Clinics of North America 2002, 31:339-352.

118. Winter WE, Harris N, Schatz D: Immunologic markers in the diagnosis, and prediction of autoimmune, type 1A diabetes. Clinical Diabetes 2002, 20:183-191.

119. Krischer JP, Cuthbertson DD, Yu L, Orban T, Maclaren N, Jackson R, Winter WE, Schatz DA, Palmer JP, Eisenbarth GS. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab. 2003 Jan;88(1):103-8.

120. Winter, W.E., Schatz, D.A., Haris, N: Type 1 diabetes islet autoantibody markers. Diabetes Technology & Therapeutics 2002; 4:817-39.

121. Winter, W.E. Newly defined genetic diabetes syndromes: maturity onset diabetes of the young. Reviews in Endocrine & Metabolic Disorders 2003; 4:43-51

122. Winter, W.E. , Schatz, D.A.: Prevention strategies for type 1 diabetes: current status and future directions. Biodrugs 2003, 17(1):39-64.

123. Winter W.E., Schatz DA. Role of the oral glucose tolerance test (OGTT) in the diagnosis and management of diabetes mellitus. Medscape Diabetes & Endocrinology 5(1), 2003. Available at: http://www.medscape.com/viewarticle/448038

124. Winter W.E., Schatz DA . Glucose dose in oral glucose tolerance testing of obese patients. Medscape Diabetes & Endocrinology 5(1), 2003. Available at: http://www.medscape.com/viewarticle/449860

125. Winter W.E., Schatz DA . Performing an oral glucose tolerance test in a pregnant woman with severe emesis. Medscape Diabetes & Endocrinology 5(1), 2003. Available at: http://www.medscape.com/viewarticle/449869

126. Winter, W.E., Harris, N.S. Self-monitoring of blood glucose: needless expense or a vital glycemic monitor? Point of Care 2003, 2:62-8

127. Winter, W.E., Harris, N.S. Bone markers in osteoporosis. Advance/Laboratory. 2003, 12(7):42-52.